Source: Reklaim
  • Reklaim (MYID) has closed the first tranche of a non-brokered private placement for aggregate gross proceeds of approximately $1,296,972
  • The company issued 19,214,406 units priced at $0.0675 per unit
  • The company may complete one or more additional tranches of the offering for aggregate gross proceeds of up to $2,500,000
  • Reklaim allows consumers to control how their data is collected and compensate them for its use, while also providing advertisers and brands a compliant data source
  • Reklaim Ltd. (MYID) opened trading at C$0.125 per share

Reklaim (MYID) has closed the first tranche of a non-brokered private placement for aggregate gross proceeds of approximately $1,296,972.

The company issued 19,214,406 units priced at $0.0675 per unit. Each unit consists of one common share and one common share purchase warrant. Each warrant is exercisable to acquire one additional common share for 36 months.

The company may complete one or more additional tranches of the offering for aggregate gross proceeds of up to $2,500,000.

The company issued 859,740 non-transferable finders warrants to certain arm’s length finders.

Reklaim expects to use all net proceeds raised for general corporate and working capital purposes.

All securities issued in the offering are subject to a four-month statutory hold period. The offering is subject to the final approval of the TSXV.

Offering compliant, first-party data to Fortune 500 brands, platforms, and data companies, Reklaim allows consumers to visit the platform, confirm their identity, and unveil data that has been collected and sold without the consumer’s explicit consent. Reklaim enables consumers to take back control of this data by setting up a Reklaim account where, should they choose to, they can be compensated for their data.

Reklaim Ltd. (MYID) opened trading at C$0.125 per share.

More From The Market Online
MDA - The Canadarm in action.

MDA’s $250M contract extension supports ISS robotics operations

MDA Space (TSX:MDA) receives a C$250 million contract extension to support robotics operations on the International Space Station.

Converge Technology signs GenAI partnership with Forum Systems

Converge Technology Solutions (TSX:CTS) signs a Generative AI-focused partnership with Forum Systems to leverage QuantumSim.